Glaukos Corp reports results for the quarter ended December 31 - Earnings Summary

• Glaukos Corp GKOS.N reported a quarterly adjusted loss of 40 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -63 cents. The mean expectation of fifteen analysts for the quarter was for a loss of 38 cents per share. Wall Street expected results to range from -60 cents to -22 cents per share.

• Revenue rose 28.1% to $105.50 million from a year ago; analysts expected $100.72 million.

• Glaukos Corp's reported EPS for the quarter was a loss of 60 cents​.

• The company reported a quarterly loss of $33.58 million.

• Glaukos Corp shares had risen by 7.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.2% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Glaukos Corp is $162.00

This summary was machine generated from LSEG data February 20 at 11:19 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)